$624 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 30.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $64,813,000 | +10.5% | 1,358,470 | +20.4% | 10.39% | +5.4% |
| ABT | Sell | ABBOTT LABS | $61,048,000 | -5.9% | 763,676 | -14.9% | 9.79% | -10.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $42,800,000 | -7.4% | 1,115,174 | -14.8% | 6.86% | -11.7% |
| GILD | Buy | GILEAD SCIENCES INC | $37,624,000 | +38.5% | 578,737 | +33.2% | 6.03% | +32.1% |
| BAX | Sell | BAXTER INTL INC | $36,445,000 | +13.1% | 448,228 | -8.5% | 5.84% | +7.9% |
| BIIB | Buy | BIOGEN INC | $35,504,000 | +256.5% | 150,200 | +353.8% | 5.69% | +239.9% |
| PKI | Sell | PERKINELMER INC | $33,059,000 | +17.2% | 343,081 | -4.5% | 5.30% | +11.8% |
| NUVA | Buy | NUVASIVE INC | $30,589,000 | +30.2% | 538,625 | +13.7% | 4.91% | +24.2% |
| BIO | Sell | BIO RAD LABS INCcl a | $26,716,000 | +19.0% | 87,397 | -9.6% | 4.28% | +13.5% |
| A | Sell | AGILENT TECHNOLOGIES INC | $22,535,000 | +6.0% | 280,351 | -11.0% | 3.61% | +1.1% |
| INCY | Sell | INCYTE CORP | $22,474,000 | +5.0% | 261,293 | -22.3% | 3.60% | +0.2% |
| MYL | New | MYLAN N V | $22,408,000 | – | 790,700 | +100.0% | 3.59% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $18,971,000 | -7.5% | 233,714 | -38.4% | 3.04% | -11.8% |
| QGEN | Sell | QIAGEN NV | $16,150,000 | +15.1% | 396,990 | -2.6% | 2.59% | +9.7% |
| CVS | Buy | CVS HEALTH CORP | $16,111,000 | -7.8% | 298,733 | +12.0% | 2.58% | -12.0% |
| PRGO | Buy | PERRIGO CO PLC | $14,834,000 | +24.8% | 308,020 | +0.4% | 2.38% | +19.0% |
| TAK | New | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $13,189,000 | – | 647,451 | +100.0% | 2.12% | – |
| ANTM | Sell | ANTHEM INC | $11,196,000 | -42.0% | 39,013 | -46.9% | 1.80% | -44.7% |
| MRK | Sell | MERCK & CO INC | $9,927,000 | -71.8% | 119,352 | -74.1% | 1.59% | -73.1% |
| PDCO | Sell | PATTERSON COMPANIES INC | $9,840,000 | +3.8% | 450,363 | -6.6% | 1.58% | -1.0% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $9,426,000 | +56.4% | 379,777 | +13.2% | 1.51% | +49.3% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $8,831,000 | +58.9% | 254,501 | -10.6% | 1.42% | +51.6% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $8,415,000 | -7.3% | 62,906 | -19.3% | 1.35% | -11.6% |
| CAH | Sell | CARDINAL HEALTH INC | $7,831,000 | -14.9% | 162,635 | -21.2% | 1.26% | -18.8% |
| PTCT | New | PTC THERAPEUTICS INC | $7,330,000 | – | 194,743 | +100.0% | 1.18% | – |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $7,023,000 | – | 218,994 | +100.0% | 1.13% | – |
| THC | Sell | TENET HEALTHCARE CORP | $6,307,000 | +37.1% | 218,684 | -18.5% | 1.01% | +30.8% |
| MCK | Sell | MCKESSON CORP | $5,794,000 | -7.2% | 49,500 | -12.4% | 0.93% | -11.5% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $4,573,000 | +1214.1% | 65,935 | +724.2% | 0.73% | +1142.4% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,847,000 | – | 57,043 | +100.0% | 0.62% | – |
| RDY | Sell | DR REDDYS LABS LTDadr | $3,567,000 | -44.7% | 88,076 | -48.6% | 0.57% | -47.3% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $2,279,000 | +28.1% | 238,857 | +54.1% | 0.36% | +22.1% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $2,093,000 | -63.5% | 376,502 | -56.4% | 0.34% | -65.1% |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -240,522 | -100.0% | -0.58% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -59,437 | -100.0% | -0.73% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -70,000 | -100.0% | -1.57% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -263,000 | -100.0% | -2.83% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -125,656 | -100.0% | -3.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.